VMD VIEMED HEALTHCARE, INC.companySEC Filings & Insider Trading Activity 2026
Latest VIEMED HEALTHCARE, INC. (VMD) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 4, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on March 16, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for VIEMED HEALTHCARE, INC. (VMD) (SEC CIK 1729149), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Investor deck filed under Reg FD, signaling management is actively engaging analysts/investors — watch for near-term catalysts or guidance updates
- • Full presentation available at viemed.com/investors and as Exhibit 99.1 — primary source for any disclosed financial or strategic detail
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released March 4, 2026 — full results in Exhibit 99.1 press release
- • Financial Supplement with additional detail available in Exhibit 99.2
Item 7.01: Regulation FD Disclosure
- • Board approved new share repurchase program, announced March 4, 2026
- • Full program details (size, duration, execution terms) contained in referenced press release exhibit — key figures not reproduced in this item
Item 8.01: Other Events
- • Board approved share buyback program on March 4, 2026, authorizing repurchase of up to 1,930,131 common shares
- • Repurchases via open market, block purchases, or other methods compliant with Rule 10b-18
Recent 8-K FilingsCurrent Reports
AI-powered analysis of VIEMED HEALTHCARE, INC. (VMD) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | — | $183.0M | $224.3M | $270.3M |
| Gross Profit | $84.7M | $112.8M | $133.2M | $155.5M |
| Operating Income | — | $14.3M | $17.9M | $22.9M |
| Net Income | — | $10.2M | $11.3M | $14.9M |
| Gross Margin | — | 61.6% | 59.4% | 57.5% |
| Op. Margin | — | 7.8% | 8.0% | 8.5% |
| Net Margin | — | 5.6% | 5.0% | 5.5% |
| Balance Sheet | ||||
| Total Assets | $117.0M | $154.9M | $177.1M | $199.2M |
| Equity | — | $113.9M | $131.4M | $141.5M |
| ROE | — | 9.0% | 8.6% | 10.6% |
Source: XBRL financial data from VIEMED HEALTHCARE, INC. (VMD) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 16, 2026 | — | Analysis | — |
10-K | Mar 4, 2026 | Dec 31, 2025 | — | |
8-K | Mar 4, 2026 | — | Analysis | — |
10-Q | Nov 5, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 6, 2025 | Jun 30, 2025 | — | |
10-Q | May 7, 2025 | Mar 31, 2025 | — | |
10-K | Mar 10, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 6, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 7, 2024 | Jun 30, 2024 | — | |
10-Q | May 6, 2024 | Mar 31, 2024 | — | |
10-K | Mar 6, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 1, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | — | |
10-Q | May 8, 2023 | Mar 31, 2023 | — | |
10-K | Mar 2, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 1, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 2, 2022 | Jun 30, 2022 | — | |
10-Q | May 3, 2022 | Mar 31, 2022 | — | |
10-K | Mar 7, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 2, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 3, 2021 | Jun 30, 2021 | — | |
10-Q | May 3, 2021 | Mar 31, 2021 | — | |
10-K | Mar 3, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 4, 2020 | Sep 30, 2020 | — | |
10-Q | Aug 4, 2020 | Jun 30, 2020 | — |
Frequently Asked Questions
What are the latest VMD SEC filings in 2026?
VIEMED HEALTHCARE, INC. (VMD) has filed a 10-K annual report on March 4, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on March 16, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did VMD file its most recent 10-K annual report?
VIEMED HEALTHCARE, INC. (VMD) filed its most recent 10-K annual report on March 4, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view VMD 10-Q quarterly reports?
VIEMED HEALTHCARE, INC. (VMD)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every VMD 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has VMD filed recently?
VIEMED HEALTHCARE, INC. (VMD)'s most recent 8-K was filed on March 16, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find VMD insider trading activity (Form 4)?
SignalX aggregates every VMD Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does VMD file with the SEC?
VIEMED HEALTHCARE, INC. (VMD) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new VMD filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for VIEMED HEALTHCARE, INC. (VMD).
What is VMD's SEC CIK number?
VIEMED HEALTHCARE, INC. (VMD)'s SEC CIK (Central Index Key) number is 1729149. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1729149 to look up all VMD filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find VMD return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from VIEMED HEALTHCARE, INC. (VMD) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of VIEMED HEALTHCARE, INC. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 29+ filings.